Published in AIDS Weekly, November 18th, 1996
The first dose, administered at a charity clinic in Mumbai (previously Bombay) in March 1994, was followed a booster dose one month later. Before the third round, however, the vaccine trial was abandoned abruptly. The doctors involved did not offer any explanation to their patients.
Today one patient is dead, another is dying of blood cancer, and two of the remaining eight could not be traced by a group of activists who are campaigning to defend the rights of Indians dying of AIDS.
ABVA, an AIDS...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.